New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  The Lancet

• Publication date

  1998-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S0140-6736(98)90017-4PMID 9736478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans

  2004cited by this paper
• Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study

  2004cited by this paper
• TREATMENT OF SEPTIC SHOCK WITH THE TUMOR NECROSIS FACTOR RECEPTOR : Fc FUSION PROTEIN C

  2000cited by this paper
• Increased Oxidative Stress in Patients With Congestive Heart Failure

  1998cited by this paper
• Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.

  1998cited by this paper
• Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart.

  1998cited by this paper
• Increased oxidative stress in patients with congestive heart failure.

  1998cited by this paper
• Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

  1998cited by this paper
• Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure.

  1998cited by this paper
• Pulmonary and systemic responses to exogenous endothelin-1 in patients with left ventricular dysfunction.

  1998cited by this paper
• Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness.

  1998cited by this paper
• Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.

  1998cited by this paper
• Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.

  1998cited by this paper
• Antioxidant effect of carvedilol and metoprolol in congestive heart failure

  1998cited by this paper
• Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation.

  1997cited by this paper
• A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

  1997cited by this paper
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

  1997cited by this paper
• Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.

  1997cited by this paper
• Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart.

  1997cited by this paper
• A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

  1997cited by this paper
• Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.

  1997cited by this paper
• Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats.

  1997cited by this paper
• Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α

  1997cited by this paper
• Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist.

  1997cited by this paper
• Molecular and cellular mechanisms of myocardial failure.

  1997cited by this paper
• Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation?

  1997cited by this paper
• Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha.

  1997cited by this paper
• Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

  1997cited by this paper
• Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

  1996cited by this paper
• Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

  1996cited by this paper
• Myocardial endothelin. Does it play a role in myocardial failure?

  1996cited by this paper
• Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.

  1996cited by this paper
• Role of oxidative stress in transition of hypertrophy to heart failure.

  1996cited by this paper
• Free radicals enhance Na+/Ca2+ exchange in ventricular myocytes.

  1996cited by this paper
• Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

  1996cited by this paper
• Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart.

  1996cited by this paper
• Oxy free radical system in heart failure and therapeutic role of oral vitamin E.

  1996cited by this paper
• Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.

  1996cited by this paper
• IL-1 beta stimulates superoxide and delayed peroxynitrite production by pulmonary vascular smooth muscle cells.

  1996cited by this paper
• Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy.

  1996cited by this paper
• Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

  1996cited by this paper
• Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha.

  1996cited by this paper
• Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats.

  1996cited by this paper
• Expression of inducible nitric oxide synthase in human heart failure.

  1996cited by this paper
• Human pulmonary circulation is an important site for both clearance and production of endothelin-1.

  1996cited by this paper
• Increased malondialdehyde in peripheral blood of patients with congestive heart failure.

  1996cited by this paper
• Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart

  1996cited by this paper
• An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis.

  1995cited by this paper
• The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta.

  1995cited by this paper
• Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes.

  1995cited by this paper
• Role of endothelin in the exercise intolerance of chronic heart failure.

  1995cited by this paper
• Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

  1995cited by this paper
• Role of nitric oxide in the regulation of myocardial function.

  1995cited by this paper
• Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.

  1995cited by this paper
• Stretch-induced programmed myocyte cell death.

  1995cited by this paper
• Endothelin in human congestive heart failure.

  1994cited by this paper
• Antioxidant changes in hypertrophied and failing guinea pig hearts.

  1994cited by this paper
• ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1.

  1994cited by this paper
• Interferon-beta induces metalloproteinase mRNA expression in human fibroblasts. Role of activator protein-1.

  1994cited by this paper
• Nitric oxide synthase activities in human myocardium.

  1993cited by this paper
• Pathogenetic mechanisms of septic shock.

  1993cited by this paper
• Evidence of oxidative stress in chronic heart failure in humans.

  1993cited by this paper
• Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical.

  1993cited by this paper
• A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.

  1993cited by this paper
• Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy.

  1992cited by this paper
• Cytokine dysregulation and acute graft-versus-host disease.

  1992cited by this paper
• Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure

  1992cited by this paper
• Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.

  1992cited by this paper
• Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy.

  1990cited by this paper
• Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy.

  1990cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990cited by this paper
• Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease.

  1990cited by this paper
• Oxpentifylline in endotoxaemia.

  1989cited by this paper
• Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline.

  1988cited by this paper
• Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline

  1988cited by this paper
• Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.

  1985cited by this paper
• [Patients with congestive heart failure. 1].

  1985cited by this paper
• Oxygen-derived free radicals in postischemic tissue injury.

  1985cited by this paper

• Umbilical Cord Matrix (Wharton Jelly) Mesenchymal Stem Cells in Next-Generation Myocardial Repair and Regeneration: Mechanisms and Pre-Clinical Evidence.

  2025cites this paper
• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.

  2025cites this paper
• Association between oxidative balance score and mortality: Prospective cohort study in a representative US population

  2025cites this paper
• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.

  2025cites this paper
• Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management

  2024cites this paper
• Targeting Key Inflammatory Mechanisms Underlying Heart Failure: A Comprehensive Review

  2023cites this paper
• Mechanisms of Kidney and Heart Cross-talk in Acute Kidney Injury

  2020cites this paper
• Panoramic Dominance of the Immune System in Cardiorenal Syndrome Type I

  2020cites this paper
• The Genetic Evidence of Burn-Induced Cardiac Mitochondrial Metabolism Dysfunction

  2020cites this paper
• The Genetic Evidence of Burn-Induced Cardiac Mitochondrial Metabolism Confusion

  2020cites this paper
• A defined, plant-based diet as a potential therapeutic approach in the treatment of heart failure: A clinical case series.

  2019cites this paper
• Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes

  2018cites this paper
• Oral nucleic acid therapy using multicompartmental delivery systems.

  2018cites this paper
• EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in mice.

  2017cites this paper
• Depression as a systemic disease

  2017cites this paper
• Endothelin-1 and nitric oxide in 3-year prognosis after acute myocardial infarction

  2017cites this paper
• University of Groningen Aspects of endothelial function testing in coronary vascular disease

  2017cites this paper
• Cardiorenal Syndrome (CRS)

  2017cites this paper
• The effect of statins on mortality in heart failure with preserved ejection fraction: a meta-analysis of propensity score analyses.

  2016cites this paper
• nducible Nitric Oxide Synthase n Severe Human Heart Failure * mpact of Mechanical Unloading andall

  2016cites this paper
• Decreased Peripheral Mitochondrial DNA Copy Number is Associated with the Risk of Heart Failure and Long-term Outcomes

  2016cites this paper
• Comparative study between the attenuation of cardiac fibrosis by mesenchymal stem cells versus colchicine

  2016cites this paper
• Biobehavioral Influences of Anxiety, Depression, and Hostility Symptoms on Health-Related Outcomes in Patients with Heart Failure

  2016cites this paper
• Advances in the Pathogenesis of Cardiorenal Syndrome Type 3

  2015cites this paper
• Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study

  2015cites this paper
• Manganese superoxide dismutase and oxidative stress modulation.

  2015cites this paper
• Clinical significance of high-sensitivity cardiac troponin T in patients with dilated cardiomyopathy.

  2015cites this paper
• Effects of lipophilic statins for heart failure: a meta-analysis of 13 randomised controlled trials.

  2014cites this paper
• Modulation of Myocardial Metabolism by 3-Ketoacyl Coenzyme a Thiolase Inhibition and Other Agents in Heart Failure Treatment

  2014cites this paper
• Tissue-Specific Deletion of Manganese Superoxide Dismutase (Mn-SOD) in Mice

  2014cites this paper
• Health status, psychological distress and inflammation in heart failure : Towards a patient-centered approach

  2014cites this paper
• Heart–kidney crosstalk and role of humoral signaling in critical illness

  2014cites this paper
• Health-related Quality of Life and Mortality in Incident Heart Failure from the Cardiovascular Health Study (CHS)

  2014cites this paper
• Kapitel 7 – Erkrankungen des Myokards

  2014cites this paper
• Pathophysiology of Heart Failure

  2013cites this paper
• Antioxidants Improve the Phenotypes of Dilated Cardiomyopathy and Muscle Fatigue in Mitochondrial Superoxide Dismutase-Deficient Mice

  2013cites this paper
• Vitamin C prevents stress-induced damage on the heart caused by the death of cardiomyocytes, through down-regulation of the excessive production of catecholamine, TNF-α, and ROS production in Gulo(-/-)Vit C-Insufficient mice.

  2013cites this paper
• Bioinformatic analysis of microarray data reveals several key genes related to heart failure.

  2013cites this paper
• Preclinical stem cell therapy in Chagas Disease: Perspectives for future research.

  2013cites this paper
• Regulation of store-operated channel molecules ORAI and STIM by oxidative stress in blood vessels

  2013cites this paper
• Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure

  2012cites this paper
• Cardio-renal syndrome type 3: epidemiology, pathophysiology, and treatment.

  2012cites this paper
• 3 Evaluation of Cardiac Function after VAD Implantation

  2012cites this paper
• Psychological vulnerability, ventricular tachyarrhythmias and mortality in implantable cardioverter defibrillator patients: is there a link?

  2012cites this paper
• Современные представления о роли факторов риска сердечно-сосудистых заболеваний в атерогенезе

  2012cites this paper
• A Comparison of Selenium Concentrations between Congestive Heart Failure Patients and Healthy Volunteers

  2012cites this paper
• Oil palm vegetation liquor: a new source of phenolic bioactives

  2011cites this paper
• S-Glutathionylation: From Molecular Mechanisms to Health Outcomes

  2011influential citation
• High Sensitivity C - Reactive Protein is Associated with Diastolic Dysfunction in Young African Americans without Clinically Evident Cardiac Disease

  2011cites this paper
• Evaluation of Cardiac Function after VAD Implantation

  2011cites this paper
• Serum -Glutamyl Transferase and Risk of Heart Failure in the Community

  2010cites this paper
• Model mice for tissue‐specific deletion of the manganese superoxide dismutase gene

  2010cites this paper
• Serum &ggr;-Glutamyl Transferase and Risk of Heart Failure in the Community

  2010cites this paper
• "Old" hearts and arteries: the role of oxidative stress.

  2010cites this paper
• Psychobiology of depression/distress in congestive heart failure

  2009cites this paper
• Effect of 3-Thienylalanine-Ornithine-Proline, New Sulfur-containing Angiotensin-converting Enzyme Inhibitor on Blood Pressure and Oxidative Stress in Spontaneously Hypertensive Rats

  2009cites this paper
• Effect of 3-Thienylalanine-Ornithine-Proline, New Sulfur-containing Angiotensin-converting Enzyme Inhibitor- on Blood Pressure and Oxidative Stress in SHRs

  2009cites this paper
• Organ crosstalk: the role of the kidney

  2009cites this paper
• Observational studies of statins in heart failure with preserved systolic function.

  2008cites this paper
• Uncoupling proteins in heart failure

  2008cites this paper
• The Regulation of Mitochondrial Uncoupling Proteins in the Heart

  2008cites this paper
• Circulating white blood cells and platelets amplify oxidative stress in heart failure

  2008cites this paper
• Role of quercetin in modulating rat cardiomyocyte gene expression profile.

  2008cites this paper
• Elevation of serum endothelins and cardiotoxicity induced by particulate matter (PM2.5) in rats with acute myocardial infarction

  2007cites this paper
• Major depressive disorder and inflammatory markers in elderly patients with heart failure.

  2007cites this paper
• Insuficiencia cardiaca en el anciano. Un problema no resuelto.

  2007cites this paper
• Cytokines in HIV-associated cardiomyopathy.

  2007cites this paper
• Gene therapy: role in myocardial protection.

  2006cites this paper
• Acute renal failure: much more than a kidney disease.

  2006cites this paper
• Cell transplantation after the coculture of skeletal myoblasts and mesenchymal stem cells in the regeneration of the myocardium scar: an experimental study in rats.

  2006cites this paper
• Recent developments of small molecule endothelin modulators

  2006influential citation
• Oxidative Stress Causes Heart Failure with Impaired Mitochondrial Respiration*

  2006cites this paper
• Oxidative mechanism and homeostasis of proteinase/antiproteinase in congestive heart failure.

  2006cites this paper
• Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart.

  2005cites this paper
• Wirkung von Sauerstoffradikalen und Angiotensin II auf die Endothelin-1 Synthese in humanen Arteria mammaria interna Segmenten

  2005influential citation
• Circulating levels of myocardial proteins predict future deterioration of congestive heart failure.

  2005cites this paper
• Inducible nitric oxide synthase in severe human heart failure: impact of mechanical unloading.

  2005cites this paper
• Molecular Therapeutic Approaches for Myocardial Protection

  2005cites this paper
• Statin Therapy May Be Associated With Lower Mortality in Patients With Diastolic Heart Failure: A Preliminary Report

  2005cites this paper
• Therapeutic Potential of TIMPs in Heart Failure

  2005cites this paper
• Differing phagocytic function of monocytes and neutrophils in Chagas' cardiopathy according to the presence or absence of congestive heart failure.

  2004cites this paper
• MR and CT assessment for ischemic cardiac disease

  2004cites this paper
• Current Perspectives on Gene and Cell-Based Therapies for Myocardial Protection, Rescue and Repair

  2004cites this paper
• Cardiovascular Pharmacogenetics

  2004cites this paper
• Efectos del carvedilol en la capacidad funcional, función ventricular izquierda, catecolaminas y estrés oxidativo en pacientes con insuficiencia cardíaca crónica

  2004influential citation
• Effects of Quinapril on Myocardial Function, Ventricular Remodeling and Cardiac Cytokine Expression in Congestive Heart Failure in the Rat

  2004cites this paper
• [Effects of carvedilol on functional capacity, left ventricular function, catecholamines and oxidative stress in patients with chronic heart failure].

  2004influential citation
• C-Reactive Protein Levels in Chronic Congestive Heart Failure

  2004cites this paper
• Vascular Cell Adhesion Molecule-1 as a Prognostic Marker in Patients with End-stage Heart Failure

  2004influential citation
• Troponin-T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats.

  2004cites this paper
• Infarction induced ventricular remodeling.

  2004cites this paper
• Carvedilol: β-Blockade and Beyond

  2004cites this paper
• Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats

  2004cites this paper
• Neurohormones and heart failure.

  2004cites this paper
• Gene and cell‐based therapies for heart disease

  2004cites this paper
• Attenuation of Oxidative Stress and Remodeling by Cardiac Inhibitor of Metalloproteinase Protein Transfer

  2004cites this paper
• Oxidative stress and heart failure

  2003cites this paper
• ACE-Inhibitors, β-Blockers, Spironolactone: Do We Need Many More Drugs to Treat Chronic Heart Failure?

  2003cites this paper
• Nesiritide: a review of its use in acute decompensated heart failure.

  2003cites this paper
• Matrix metalloproteinase in left ventricular remodeling and heart failure

  2003cites this paper